Cytochrome P450 (P450) 2U1 has been shown to be expressed, at the mRNA level, in human thymus, brain, and several other tissues. Recombinant P450 2U1 was purified and used as a reagent in a metabolomic search for substrates in bovine brain. In addition to fatty acid oxidation reactions, an oxidation of endogenous N-arachidonoylserotonin was characterized. Subsequent NMR and mass spectrometry and chemical synthesis showed that the main product was the result of C-2 oxidation of the indole ring, in contrast to other human P450s that generated different products. N-Arachidonoylserotonin, first synthesized chemically and described as an inhibitor of fatty acid amide hydrolase, had previously been found in porcine and mouse intestine; we demonstrated its presence in bovine and human brain samples. The product (2-oxo) was 4-fold less active than N-arachidonoylserotonin in inhibiting fatty acid amide hydrolase. The rate of oxidation of N-arachidonoylserotonin was similar to that of arachidonic acid, one of the previously identified fatty acid substrates of P450 2U1. The demonstration of the oxidation of N-arachidonoylserotonin by P450 2U1 suggests a possible role in human brain and possibly other sites.

Department of Biochemistry and Center in Molecular Toxicology Vanderbilt University School of Medicine Nashville Tennessee 37232 0146

Department of Biochemistry and Center in Molecular Toxicology Vanderbilt University School of Medicine Nashville Tennessee 37232 0146; Pharmacology and Toxicology Division Institute of Molecular and Translational Medicine Palacky University Olomouc 775 15 Olomouc Czech Republic

Zobrazit více v PubMed

Ortiz de Montellano P. R. (ed.) (2005) Cytochrome P450: Structure, Mechanism, and Biochemistry, 3rd Ed., Kluwer Academic/Plenum Publishers, New York

Coon M. J. (2005) Cytochrome P450: nature's most versatile biological catalyst. Annu. Rev. Pharmacol. Toxicol. 45, 1–25 PubMed

Guengerich F. P. (2005) Human cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemistry, 3rd Ed., Ortiz de Montellano P. R. (ed), pp. 377–530, Kluwer Academic/Plenum Publishers, New York

Mast N., Norcross R., Andersson U., Shou M., Nakayama K., Bjorkhem I., Pikuleva I. A. (2003) Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry 42, 14284–14292 PubMed

Mast N., Charvet C., Pikuleva I. A., Stout C. D. (2010) Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain. J. Biol. Chem. 285, 31783–31795 PubMed PMC

Guengerich F. P., Tang Z., Salamanca-Pinzón S. G., Cheng Q. (2010) Characterizing proteins of unknown function: orphan cytochrome P450 enzymes as a paradigm. Mol. Interv. 10, 153–163 PubMed PMC

Mangelsdorf D. J., Evans R. M. (1995) The RXR heterodimers and orphan receptors. Cell 83, 841–850 PubMed

Hanson A. D., Pribat A., Waller J. C., de Crécy-Lagard V. (2010) “Unknown” proteins and “orphan” enzymes: the missing half of the engineering parts list-and how to find it. Biochem. J. 425, 1–11 PubMed PMC

Johnson E. F., Stout C. D. (2013) Structural diversity of eukaryotic membrane cytochrome P450s. J. Biol. Chem. 288, 17082–17090 PubMed PMC

Gerlt J. A., Babbitt P. C., Jacobson M. P., Almo S. C. (2012) Divergent evolution in enolase superfamily: strategies for assigning functions. J. Biol. Chem. 287, 29–34 PubMed PMC

Chun Y. J., Shimada T., Sanchez-Ponce R., Martin M. V., Lei L., Zhao B., Kelly S. L., Waterman M. R., Lamb D. C., Guengerich F. P. (2007) Electron transport pathway for a Streptomyces cytochrome P450: cytochrome P450 105D5-catalyzed fatty acid hydroxylation in Streptomyces coelicolor A3(2). J. Biol. Chem. 282, 17486–17500 PubMed

Saghatelian A., Trauger S. A., Want E. J., Hawkins E. G., Siuzdak G., Cravatt B. F. (2004) Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43, 14332–14339 PubMed

Sanchez-Ponce R., Guengerich F. P. (2007) Untargeted analysis of mass spectrometry data for elucidation of metabolites and function of enzymes. Anal. Chem. 79, 3355–3362 PubMed PMC

Xiao Y., Guengerich F. P. (2012) Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids. J. Lipid Res. 53, 1610–1617 PubMed PMC

Guengerich F. P., Cheng Q. (2011) Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology. Pharmacol. Rev. 63, 684–699 PubMed PMC

Jakoby W. B. (1980) Detoxication enzymes. In Enzymatic Basis of Detoxication (Jakoby W. B. ed.) Vol. 1, pp. 1–6, Academic Press, New York

Karlgren M., Backlund M., Johansson I., Oscarson M., Ingelman-Sundberg M. (2004) Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem. Biophys. Res. Commun. 315, 679–685 PubMed

Chuang S. S., Helvig C., Taimi M., Ramshaw H. A., Collop A. H., Amad M., White J. A., Petkovich M., Jones G., Korczak B. (2004) CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes ω- and (ω-1)-hydroxylation of fatty acids. J. Biol. Chem. 279, 6305–6314 PubMed

Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J. B. (2005) Expression patterns of mouse and human CYP orthologs (families 1–4) during development and in different adult tissues. Arch. Biochem. Biophys. 436, 50–61 PubMed

Jarrar Y. B., Cho S. A., Oh K. S., Kim D. H., Shin J. G., Lee S. J. (2013) Identification of cytochrome P450s involved in the metabolism of arachidonic acid in human platelets. Prostaglandins, Leukot., Essent. Fatty Acids 89, 227–234 PubMed

Bisogno T., Melck D., De Petrocellis L., Bobrov M., Gretskaya N. M., Bezuglov V. V., Sitachitta N., Gerwick W. H., Di Marzo V. (1998) Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem. Biophys. Res. Commun. 248, 515–522 PubMed

Patricelli M. P., Cravatt B. F. (1999) Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. Biochemistry 38, 14125–14130 PubMed

Verhoeckx K. C., Voortman T., Balvers M. G., Hendriks H. F., Wortelboer H. M., Witkamp R. F. (2011) Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract. Biochim. Biophys. Acta 1811, 578–586 PubMed

Hanna I. H., Teiber J. F., Kokones K. L., Hollenberg P. F. (1998) Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities. Arch. Biochem. Biophys. 350, 324–332 PubMed

Guengerich F. P. (2005) Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 440, 204–211 PubMed

Shimada T., Misono K. S., Guengerich F. P. (1986) Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 261, 909–921 PubMed

Hoover D. M., Lubkowski J. (2002) DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res. 30, e43. PubMed PMC

Wu Z. L., Qiao J., Zhang Z. G., Guengerich F. P., Liu Y., Pei X. Q. (2009) Enhanced bacterial expression of several mammalian cytochrome P450s by codon optimization and chaperone coexpression. Biotechnol. Lett. 31, 1589–1593 PubMed PMC

Wu Z. L., Sohl C. D., Shimada T., Guengerich F. P. (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol. Pharmacol. 69, 2007–2014 PubMed

Parikh A., Gillam E. M., Guengerich F. P. (1997) Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15, 784–788 PubMed

Nishihara K., Kanemori M., Kitagawa M., Yanagi H., Yura T. (1998) Chaperone coexpression plasmids: differential and synergistic roles of DnaK-DnaJ-GrpE and GroEL-GroES in assisting folding of an allergen of Japanese cedar pollen, Cryj2, in Escherichia coli. Appl. Environ. Microbiol. 64, 1694–1699 PubMed PMC

Omura T., Sato R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370–2378 PubMed

Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685 PubMed

Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G. M., Carnemolla B., Orecchia P., Zardi L., Righetti P. G. (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25, 1327–1333 PubMed

Tang Z., Martin M. V., Guengerich F. P. (2009) Elucidation of functions of human cytochrome P450 enzymes: identification of endogenous substrates in tissue extracts using metabolomic and isotopic labeling approaches. Anal. Chem. 81, 3071–3078 PubMed PMC

Guengerich F. P. (1978) Destruction of heme and hemoproteins mediated by liver microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase. Biochemistry 17, 3633–3639 PubMed

Guengerich F. P., Bartleson C. J. (2007) Analysis and characterization of enzymes and nucleic acids. in Principles and Methods of Toxicology (Hayes A. W., ed.) 5th Ed., pp. 1981–2048, CRC Press, Boca Raton, FL

Nordström A., O'Maille G., Qin C., Siuzdak G. (2006) Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. Anal. Chem. 78, 3289–3295 PubMed PMC

Katajamaa M., Miettinen J., Oresic M. (2006) MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22, 634–636 PubMed

Pluskal T., Castillo S., Villar-Briones A., Oresic M. (2010) MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11, 395. PubMed PMC

Dierks E. A., Zhang Z., Johnson E. F., Ortiz de Montellano P. R. (1998) The catalytic site of cytochrome P4504A11 (CYP4A11) and its L131F mutant. J. Biol. Chem. 273, 23055–23061 PubMed

Meinnel T., Mechulam Y., Blanquet S. (1993) Methionine as translation start signal: a review of the enzymes of the pathway in Escherichia coli. Biochimie 75, 1061–1075 PubMed

Dong M. S., Bell L. C., Guo Z., Phillips D. R., Blair I. A., Guengerich F. P. (1996) Identification of retained N-formylmethionine in bacterial recombinant mammalian cytochrome P450 proteins with the N-terminal sequence MALLLAVFL: roles of residues 3–5 in retention and membrane topology. Biochemistry 35, 10031–10040 PubMed

Smith C. A., Want E. J., O'Maille G., Abagyan R., Siuzdak G. (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779–787 PubMed

Tautenhahn R., Patti G. J., Rinehart D., Siuzdak G. (2012) XCMS online: a web-based platform to process untargeted metabolomic data. Anal. Chem. 84, 5035–5039 PubMed PMC

Schenkman J. B., Remmer H., Estabrook R. W. (1967) Spectral studies of drug interaction with hepatic microsomal cytochrome P-450. Mol. Pharmacol. 3, 113–123 PubMed

Goldstone J. V., McArthur A. G., Kubota A., Zanette J., Parente T., Jönsson M. E., Nelson D. R., Stegeman J. J. (2010) Identification and developmental expression of the full complement of cytochrome P450 genes in zebrafish. BMC Genomics 11, 643. PubMed PMC

Wu K. C., Cui J. Y., Klaassen C. D. (2012) Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver. PLoS One 7, e39006. PubMed PMC

Gillam E. M., Notley L. M., Cai H., De Voss J. J., Guengerich F. P. (2000) Oxidation of indole by cytochrome P450 enzymes. Biochemistry 39, 13817–13824 PubMed

Ma X., Idle J. R., Krausz K. W., Gonzalez F. J. (2005) Metabolism of melatonin by human cytochromes P450. Drug Metab. Dispos. 33, 489–494 PubMed

Lu A. Y., Coon M. J. (1968) Role of hemoprotein P-450 in fatty acid ω-hydroxylation in a soluble enzyme system from liver microsomes. J. Biol. Chem. 243, 1331–1332 PubMed

Boddupalli S. S., Pramanik B. C., Slaughter C. A., Estabrook R. W., Peterson J. A. (1992) Fatty acid monooxygenation by P450BM-3: product identification and proposed mechanisms for the sequential hydroxylation reactions. Arch. Biochem. Biophys. 292, 20–28 PubMed

Fujishiro T., Shoji O., Nagano S., Sugimoto H., Shiro Y., Watanabe Y. (2011) Crystal structure of H2O2-dependent cytochrome P450SPα with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position. J. Biol. Chem. 286, 29941–29950 PubMed PMC

Lee D. S., Yamada A., Sugimoto H., Matsunaga I., Ogura H., Ichihara K., Adachi S., Park S. Y., Shiro Y. (2003) Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis: crystallographic, spectroscopic, and mutational studies. J. Biol. Chem. 278, 9761–9767 PubMed

Maione S., De Petrocellis L., de Novellis V., Moriello A. S., Petrosino S., Palazzo E., Rossi F. S., Woodward D. F., Di Marzo V. (2007) Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Br. J. Pharmacol. 150, 766–781 PubMed PMC

Gilmore A. J., Heblinski M., Reynolds A., Kassiou M., Connor M. (2012) Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT. Br. J. Pharmacol. 167, 1076–1088 PubMed PMC

Yoo J. M., Sok D. E., Kim M. R. (2013) Effect of endocannabinoids on IgE-mediated allergic response in RBL-2H3 cells. Int. Immunopharmacol. 17, 123–131 PubMed

Jones P., Suggett A. (1968) The catalse-hydrogen peroxide system: kinetics of catalatic action at high substrate concentrations. Biochem. J. 110, 617–620 PubMed PMC

Leung D., Saghatelian A., Simon G. M., Cravatt B. F. (2006) Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45, 4720–4726 PubMed PMC

Dong M. S., Yamazaki H., Guo Z., Guengerich F. P. (1996) Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 327, 11–19 PubMed

Guengerich F. P., Gillam E. M., Shimada T. (1996) New applications of bacterial systems to problems in toxicology. Crit. Rev. Toxicol. 26, 551–583 PubMed